Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

79.400
-3.150-3.82%
Volume:8.01M
Turnover:647.28M
Market Cap:137.76B
PE:-1.32K
High:83.500
Open:82.550
Low:79.200
Close:82.550
52wk High:109.100
52wk Low:36.600
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:0.76
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.060
ROE:8.43%
ROA:2.65%
PB:8.44
PE(LYR):-1,323.33
PS:10.66

Loading ...

Analysis of Hang Seng Index and Stock Connect Adjustments in Q3

Deep News
·
Nov 25, 2025

Assessing Innovent Biologics (SEHK:1801) Valuation Following Strong Share Price Momentum

Simply Wall St.
·
Nov 24, 2025

HK Market Wrap: Alibaba (09988) Fuels Tech Rally; Defense Stocks Surge Amid Tensions

Stock News
·
Nov 24, 2025

Innovent Biologics Joins Hang Seng Index

Reuters
·
Nov 24, 2025

HK Stock Movement | INNOVENT BIO (01801) Rises Nearly 5%, Set to Join Hang Seng Index on Dec 8

Stock News
·
Nov 24, 2025

Market Has Priced in Negative Sentiment; Multiple Catalysts Emerge This Week

Stock News
·
Nov 24, 2025

Hong Kong Emerges as Safe Haven for Capital; Innovent Bio's (01801) Weight-Loss Drug Meets Primary and Secondary Endpoints

Stock News
·
Nov 24, 2025

Hang Seng HKEX Connect China Enterprises Index Latest Adjustment Announced: China Hongqiao (01378), Yum China (09987) Among 4 New Additions

Stock News
·
Nov 21, 2025

Hang Seng Index Q3 Review Results Announced: INNOVENT BIO (01801) Added, Constituents Increase to 89

Stock News
·
Nov 21, 2025

Is Mazdutide’s Phase 3 Success Reshaping the Investment Case for Innovent Biologics (SEHK:1801)?

Simply Wall St.
·
Nov 21, 2025

Hong Kong Stocks Movement | Biotech Concept Stocks Lead Declines as BD Deals Cool and Rate Cut Expectations Fade

Stock News
·
Nov 21, 2025

HK Stock Movement | INNOVENT BIO (01801) Rises Nearly 3% in Late Trading as Company Prepares to Submit New Drug Application for Mazdutide 9mg for Adult Weight Control

Stock News
·
Nov 20, 2025

Mazdutide Achieves 20% Weight Loss in Phase 3 Obesity Trial, Innovent Plans China NDA Submission

Reuters
·
Nov 20, 2025

Mazdutide 9 Mg Achieves up to 20.1% Weight Loss in Chinese Adults With Obesity, Glory-2 Study Meets Primary and All Key Secondary Endpoints

THOMSON REUTERS
·
Nov 20, 2025

JPMorgan Increases Stake in INNOVENT BIO (01801) by Approximately 1.44 Million Shares at HK$84.73 per Share

Stock News
·
Nov 17, 2025

Market Outlook: Heavy Pressure This Week; Focus on NVIDIA (NVDA.US) Earnings

Stock News
·
Nov 17, 2025

Encouraging Early Data for IBI3016 Could Be a Game Changer for Innovent Biologics (SEHK:1801)

Simply Wall St.
·
Nov 14, 2025

China Galaxy Securities Maintains "Buy" Rating for INNOVENT BIO (01801), Highlights Breakthrough in Diversified Pipeline Driving Second Growth Curve

Stock News
·
Nov 14, 2025

Chinese doctors call for insurance coverage for weight-loss drugs

Reuters
·
Nov 14, 2025

Active Southbound Stock Connect Trading on November 13

Stock News
·
Nov 13, 2025